Crossref journal-article
Elsevier BV
Neoplasia (78)
Bibliography

Jacobs, A., Breakefield, X. O., & Fraefel, C. (1999). HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and Applications. Neoplasia, 1(5), 402–416.

Authors 3
  1. Andreas Jacobs (first)
  2. Xandra O. Breakefield (additional)
  3. Cornel Fraefel (additional)
References 202 Referenced 58
  1. 10.1016/0092-8674(81)90247-6 / Cell / A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth by Post (1981)
  2. {'key': '10.1038/sj.neo.7900056_bib2', 'series-title': 'Methods in Molecular Medicine, Gene Therapy Protocols', 'article-title': 'HSV-1 Vectors for Therapy of Experimental CNS Tumors', 'author': 'Herrlinger', 'year': '1999'} / Methods in Molecular Medicine, Gene Therapy Protocols / HSV-1 Vectors for Therapy of Experimental CNS Tumors by Herrlinger (1999)
  3. 10.1038/sj.gt.3300497 / Gene Ther / Rapid method for construction of recombinant HSV gene transfer vectors by Krisky (1997)
  4. 10.1038/nm0397-357 / Nat Med / Engineering herpes simplex virus vectors for gene transfer to neurons by Fink (1997)
  5. {'key': '10.1038/sj.neo.7900056_bib5', 'first-page': '739', 'article-title': 'Transfer and expression of the IacZ gene in rat brain neurons mediated by herpes simplex virus mutants', 'volume': '2', 'author': 'Chiocca', 'year': '1990', 'journal-title': 'New Biol'} / New Biol / Transfer and expression of the IacZ gene in rat brain neurons mediated by herpes simplex virus mutants by Chiocca (1990)
  6. 10.1128/JVI.56.2.558-570.1985 / J Virol / Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4 by DeLuca (1985)
  7. 10.1146/annurev.mi.49.100195.003331 / Annu Rev Microbiol / Development and application of herpes simplex virus vectors for human gene therapy by Glorioso (1995)
  8. 10.1128/JVI.66.5.2952-2965.1992 / J Virol / Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1 by Johnson (1992)
  9. 10.1099/0022-1317-68-12-3009 / J Gen Virol / Herpes simplex virus genes involved in latency in vitro by Russell (1987)
  10. 10.1128/JVI.68.10.6347-6362.1994 / J Virol / Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function by Johnson (1994)
  11. 10.1038/sj.gt.3300755 / Gene Ther / Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications by Krisky (1998)
  12. 10.1038/sj.gt.3300766 / Gene Ther / Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons by Krisky (1998)
  13. 10.1073/pnas.93.21.11319 / Proc Natl Acad Sci USA / Replication-defective herpes simplex virus vectors for gene transfer in vivo by Marconi (1996)
  14. 10.1128/JVI.70.9.6358-6369.1996 / J Virol / Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22 by Wu (1996)
  15. 10.1128/JVI.71.6.4614-4625.1997 / J Virol / The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27 by Samaniego (1997)
  16. 10.1128/JVI.71.10.7807-7813.1997 / J Virol / Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis by Preston (1997)
  17. 10.1006/viro.1996.8424 / Virology / Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression by Preston (1997)
  18. 10.1128/JVI.72.4.3307-3320.1998 / J Virol / Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins by Samaniego (1998)
  19. 10.1073/pnas.96.7.4078 / Proc Natl Acad Sci USA / Herpes simplex virus vector-mediated expression of bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo by Yamada (1999)
  20. 10.1126/science.2173860 / Science / Mapping of herpes simplex virus-1 neurovirulence to 34.5, a gene nonessential for growth in culture by Chou (1990)
  21. 10.1172/JCI116527 / J Clin Invest / Replication, establishment of latency, and induced reactivation of herpes simplex virus 34.5 deletion mutants in rodent models by Whitley (1993)
  22. 10.1227/00006123-199304000-00016 / Neurosurgery / Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir by Markert (1993)
  23. 10.1073/pnas.92.5.1411 / Proc Natl Acad Sci USA / Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma by Chambers (1995)
  24. {'key': '10.1038/sj.neo.7900056_bib24', 'first-page': '886', 'article-title': 'Gene delivery to the central and peripheral nervous systems of mice using HSVI ICP34.5 deletion mutant vectors', 'volume': '3', 'author': 'Coffin', 'year': '1996', 'journal-title': 'Gene Ther'} / Gene Ther / Gene delivery to the central and peripheral nervous systems of mice using HSVI ICP34.5 deletion mutant vectors by Coffin (1996)
  25. 10.1046/j.1460-9568.1998.00339.x / Eur J Neurosci / Delivery of a constitutively active form of the heat shock factor using a virus vector protects neuronal cells from thermal or ischaemic stress but not from apoptosis by Wagstaff (1998)
  26. 10.1074/jbc.274.8.5061 / J Biol Chem / Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector by Wagstaff (1999)
  27. 10.1007/BF02736851 / J Mol Neurosci / Gene delivery to rat enteric neurons using herpes simplex virus-based vectors by Howard (1997)
  28. 10.1128/JVI.64.7.3269-3279.1990 / J Virol / Regulation and cell-typespecific activity of a promoter located upstream of the latencyassociated transcript of herpes simplex virus type 1 by Batchelor (1990)
  29. 10.1128/JVI.64.10.5019-5028.1990 / J Virol / Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript by Zwaagstra (1990)
  30. 10.1073/pnas.86.19.7596 / Proc Natl Acad Sci USA / Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse by Ho (1989)
  31. 10.1128/JVI.71.4.3197-3207.1997 / J Virol / Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system by Lachmann (1997)
  32. 10.1038/ng0892-379 / Nat Genet / Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice by Wolfe (1992)
  33. 10.1128/JVI.68.4.2239-2252.1994 / J Virol / A novel latencyactive promoter is contained within the herpes simplex virus type 1 UL flanking repeats by Goins (1994)
  34. 10.1128/JVI.73.1.519-532.1999 / J Virol / Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity by Goins (1999)
  35. 10.1007/BF00711459 / Cell Mol Neurobiol / Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter by Andersen (1993)
  36. 10.1089/hum.1992.3.1-11 / Hum Gene Ther / In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer by Fink (1992)
  37. 10.1128/JVI.68.11.7148-7158.1994 / J Virol / Long-term promoter activity during herpes simplex virus latency by Lokensgard (1994)
  38. 10.1089/hum.1996.7.12-1447 / Hum Gene Ther / Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome by Carpenter (1996)
  39. 10.1016/0896-6273(90)90171-B / Neuron / A latent, nonpathogenic HSV-1-derived vector stably expresses beta- galactosidase in mouse neurons by Dobson (1990)
  40. {'key': '10.1038/sj.neo.7900056_bib40', 'first-page': '5276', 'article-title': 'Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy', 'volume': '46', 'author': 'Moolten', 'year': '1986', 'journal-title': 'Cancer Res'} / Cancer Res / Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy by Moolten (1986)
  41. 10.1073/pnas.89.1.33 / Proc Natl Acad Sci USA / Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system by Mullen (1992)
  42. 10.1093/jnci/90.5.370 / J Natl Cancer Inst / Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-flu orocytosine/cytosine deaminase gene therapies by Aghi (1998)
  43. 10.1089/hum.1993.4.5-589 / Hum Gene Ther / Retrovirally transduced Escherichia coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication by Mroz (1993)
  44. {'key': '10.1038/sj.neo.7900056_bib44', 'first-page': '155', 'article-title': 'Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine', 'volume': '3', 'author': 'Tamiya', 'year': '1996', 'journal-title': 'Cancer Gene Ther'} / Cancer Gene Ther / Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine by Tamiya (1996)
  45. {'key': '10.1038/sj.neo.7900056_bib45', 'first-page': '581', 'article-title': 'Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy', 'volume': '55', 'author': 'Chen', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy by Chen (1995)
  46. 10.1089/hum.1998.9.9-1261 / Hum Gene Ther / New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol by Rainov (1998)
  47. 10.1089/hum.1994.5.8-969 / Hum Gene Ther / Experimental tumor therapy in mice using the cyclopho sphamide-activating cytochrome P450 2B1 gene by Wei (1994)
  48. 10.1038/nm0596-567 / Nat Med / Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo by Manome (1996)
  49. 10.1038/nm0996-985 / Nat Med / Retrovirus-mediated wildtype p53 gene transfer to tumors of patients with lung cancer by Roth (1996)
  50. 10.1016/S1055-3207(18)30262-X / Surg Oncol Clin N Am / Gene therapy for tumors of the central nervous system by Chung (1998)
  51. 10.1016/0042-6822(88)90079-7 / Virology / Beta -galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse by Ho (1988)
  52. 10.3171/jns.1992.77.4.0590 / J Neurosurg / Expanded spectrum of viral therapy in the treatment of nervous system tumors by Markert (1992)
  53. 10.1126/science.1851332 / Science / Experimental therapy of human glioma by means of a genetically engineered virus mutant by Martuza (1991)
  54. 10.1093/jnci/86.16.1209 / J Natl Cancer Inst / Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1 by Jia (1994)
  55. 10.3171/jns.1996.85.4.0662 / J Neurosurg / Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytoma by Jia (1996)
  56. 10.1128/JVI.71.7.5124-5132.1997 / J Virol / Transcriptional targeting of herpes simplex virus for cell-specific replication by Miyatake (1997)
  57. 10.1007/BF01306455 / J Neurooncol / Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats by Kaplitt (1994)
  58. {'key': '10.1038/sj.neo.7900056_bib58', 'first-page': '323', 'article-title': 'Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase', 'volume': '1', 'author': 'Boviatsis', 'year': '1994', 'journal-title': 'Gene Ther'} / Gene Ther / Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase by Boviatsis (1994)
  59. 10.1089/hum.1994.5.2-183 / Hum Gene Ther / Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors by Boviatsis (1994)
  60. {'key': '10.1038/sj.neo.7900056_bib60', 'first-page': '5745', 'article-title': 'Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene', 'volume': '54', 'author': 'Boviatsis', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene by Boviatsis (1994)
  61. 10.1128/JVI.62.1.196-205.1988 / J Virol / Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 IacZ insertion mutant by Goldstein (1988)
  62. {'key': '10.1038/sj.neo.7900056_bib62', 'first-page': '3963', 'article-title': 'Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductasedeficient herpes simplex viral mutant', 'volume': '54', 'author': 'Mineta', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductasedeficient herpes simplex viral mutant by Mineta (1994)
  63. 10.1099/0022-1317-75-9-2367 / J Gen Virol / Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2 by Brown (1994)
  64. 10.1099/0022-1317-72-3-631 / J Gen Virol / Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the ‘a’ sequence by MacLean (1991)
  65. 10.1038/bjc.1996.431 / Br J Cancer / Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours—evaluation of a potentially effective clinical therapy by McKie (1996)
  66. 10.1038/nm0995-938 / Nat Med / Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas by Mineta (1995)
  67. 10.1089/hum.1997.8.17-2057 / Hum Gene Ther / Therapeutic efficiency and safety of a second-generation replication-conditional HSVI vector for brain tumor gene therapy by Kramm (1997)
  68. 10.1089/hum.1997.8.5-533 / Hum Gene Ther / A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors by Pyles (1997)
  69. {'key': '10.1038/sj.neo.7900056_bib69', 'first-page': '1502', 'article-title': 'Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors', 'volume': '57', 'author': 'Andreansky', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors by Andreansky (1997)
  70. {'key': '10.1038/sj.neo.7900056_bib70', 'first-page': '636', 'article-title': 'Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant', 'volume': '73', 'author': 'Kesari', 'year': '1995', 'journal-title': 'Lab Invest'} / Lab Invest / Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant by Kesari (1995)
  71. 10.1097/00005072-199612000-00010 / J Neuropathol Exp Neurol / Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS by Lasner (1996)
  72. 10.1006/viro.1995.1382 / Virology / Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant by Randazzo (1995)
  73. 10.1046/j.1365-2990.1998.00133.x / Neuropathol Appl Neurobiol / Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy by McKie (1998)
  74. 10.1038/nm0298-133c / Nat Med / Therapeutic replication-competent herpes virus by Rampling (1998)
  75. 10.1128/JVI.71.7.5560-5569.1997 / J Virol / The range and distribution of murine central nervous system cells infected with the gamma(1)34.5-mutant of herpes simplex virus 1 by Markovitz (1997)
  76. 10.1099/0022-1317-79-3-525 / J Gen Virol / A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system by Kesari (1998)
  77. 10.1016/S0306-4522(97)00513-7 / Neuroscience / A gamma 34.5 mutant of herpes simplex 1 causes severe inflammation in the brain by McMenamin (1998)
  78. 10.1038/sj.gt.3300639 / Gene Ther / Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS by McMenamin (1998)
  79. 10.3109/13550289809113487 / J Neurovirol / Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice by Lasner (1998)
  80. 10.1038/sj.gt.3300550 / Gene Ther / Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins by Andreansky (1998)
  81. 10.1038/sj.gt.3300546 / Gene Ther / Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors by Advani (1998)
  82. 10.1097/00000658-199609000-00008 / Ann Surg / Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus by Carroll (1996)
  83. 10.1089/hum.1996.7.16-1989 / Hum Gene Ther / Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment by Kramm (1996)
  84. 10.1089/hum.1996.7.3-291 / Hum Gene Ther / Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors by Kramm (1996)
  85. {'key': '10.1038/sj.neo.7900056_bib85', 'first-page': '15', 'article-title': 'Imaging HSV-1 vector replication and gene delivery in vivo', 'volume': '01', 'author': 'Jacobs', 'year': '1999', 'journal-title': 'J Gene Med'} / J Gene Med / Imaging HSV-1 vector replication and gene delivery in vivo by Jacobs (1999)
  86. 10.1038/nbt0598-444 / Nat Biotechnol / An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy by Chase (1998)
  87. {'key': '10.1038/sj.neo.7900056_bib87', 'series-title': 'Cancer Res', 'article-title': 'Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/CYP2B1 and ganciclovir/HSV-TK gene therapies', 'author': 'Aghi', 'year': '1999'} / Cancer Res / Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/CYP2B1 and ganciclovir/HSV-TK gene therapies by Aghi (1999)
  88. 10.1038/sj.gt.3300643 / Gene Ther / Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector by Herrlinger (1998)
  89. 10.1038/sj.gt.3300535 / Gene Ther / Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1 by Wang (1997)
  90. {'key': '10.1038/sj.neo.7900056_bib90', 'first-page': '4752', 'article-title': 'Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1', 'volume': '55', 'author': 'Yazaki', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1 by Yazaki (1995)
  91. 10.1128/AAC.33.8.1395 / Antimicrob. Agents Chemother / Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir by Coen (1989)
  92. 10.1089/hum.1998.9.15-2177 / Hum Gene Ther / Treatment of human breast cancer in a brain metastatic model by G207, a replicationcompetent multimutated herpes simplex virus 1 by Toda (1998)
  93. 10.1089/10430349950018832 / Hum Gene Ther / Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity by Toda (1999)
  94. 10.1038/nm1297-1323 / Nat Med / Act locally, think globally by Martuza (1997)
  95. {'key': '10.1038/sj.neo.7900056_bib95', 'first-page': '527', 'article-title': 'Anatomy of herpes simplex virus DNA', 'volume': '20', 'author': 'Frenkel', 'year': '1976', 'journal-title': 'VI. Defective DNA originates from the S component. J Virol'} / VI. Defective DNA originates from the S component. J Virol / Anatomy of herpes simplex virus DNA by Frenkel (1976)
  96. 10.1128/JVI.29.3.1065-1077.1979 / J Virol / Structure and origin of defective genomes contained in serially passaged herpes simplex virus type 1 (Justin) by Locker (1979)
  97. 10.1128/JVI.43.2.574-593.1982 / J Virol / Structure and expression of class II defective herpes simplex virus genomes encoding infected cell polypeptide number 8 by Locker (1982)
  98. 10.1016/0042-6822(85)90351-4 / Virology / The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes by Kwong (1985)
  99. 10.1016/0092-8674(82)90035-6 / Cell / The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector by Spaete (1982)
  100. 10.1128/JVI.29.1.275-284.1979 / J Virol / Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperaturesensitive mutant tsK by Preston (1979)
  101. 10.1126/science.2843986 / Science / A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons by Geller (1988)
  102. 10.1099/0022-1317-71-8-1775 / J Gen Virol / A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture by Paterson (1990)
  103. 10.1016/0042-6822(85)90184-9 / Virology / Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA by Davidson (1985)
  104. 10.1073/pnas.87.22.8950 / Proc Natl Acad Sci USA / An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology by Geller (1990)
  105. 10.1128/JVI.63.1.18-27.1989 / J Virol / Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient by McCarthy (1989)
  106. 10.1016/0042-6822(92)90062-T / Virology / Evidence that the herpes simplex virus immediate early protein ICP27 acts posttranscriptionally during infection to regulate gene expression by Smith (1992)
  107. 10.2144/19962003460 / Biotechniques / Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells by Lim (1996)
  108. 10.1006/viro.1996.0081 / Virology / Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals by Berthomme (1996)
  109. 10.1089/hum.1996.7.16-2003 / Hum Gene Ther / A novel ‘piggyback’ packaging system for herpes simplex virus amplicon vectors by Pechan (1996)
  110. 10.1002/(SICI)1521-2254(199905/06)1:3<176::AID-JGM35>3.0.CO;2-T / J Gene Med. / Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas by Pechan (1999)
  111. 10.1006/viro.1993.1572 / Virology / A cosmid-based system for constructing mutants of herpes simplex virus type 1 by Cunningham (1993)
  112. 10.1128/JVI.70.10.7190-7197.1996 / J Virol / Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells by Fraefel (1996)
  113. 10.1097/00001756-199712010-00029 / NeuroReport / Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo by Aboody-Guterman (1997)
  114. 10.1007/BF03401718 / Mol Med / Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors by Fraefel (1997)
  115. {'key': '10.1038/sj.neo.7900056_bib115', 'series-title': 'Gene Therapy for Neurological Disorders and Brain Tumors', 'first-page': '63', 'article-title': 'HSV-1 Amplicon', 'author': 'Fraefel', 'year': '1998'} / Gene Therapy for Neurological Disorders and Brain Tumors / HSV-1 Amplicon by Fraefel (1998)
  116. 10.1089/hum.1997.8.3-359 / Hum Gene Ther / HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells by Johnston (1997)
  117. 10.1089/hum.1998.9.18-2787 / Hum Gene Ther / Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors by Saeki (1998)
  118. {'key': '10.1038/sj.neo.7900056_bib118', 'series-title': 'Viral Vectors: Basic Science and Gene Therapy', 'article-title': 'Herpes Simplex Virus Type 1-Based Amplicon and Hybrid Amplicon Vector Systems', 'author': 'Saeki', 'year': '1999'} / Viral Vectors: Basic Science and Gene Therapy / Herpes Simplex Virus Type 1-Based Amplicon and Hybrid Amplicon Vector Systems by Saeki (1999)
  119. 10.1128/JVI.72.9.7137-7143.1998 / J Virol / An enhanced packaging system for helper-dependent herpes simplex virus vectors by Stavropoulos (1998)
  120. 10.1073/pnas.90.8.3655 / Proc Natl Acad Sci USA / Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene by Ho (1993)
  121. 10.1128/JVI.69.8.4593-4599.1995 / J Virol / Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector by Smith (1995)
  122. 10.1089/hum.1996.7.16-2015 / Hum Gene Ther / Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector by Jin (1996)
  123. 10.1073/pnas.91.19.8979 / Proc Natl Acad Sci USA / Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector by Kaplitt (1994)
  124. 10.1128/JVI.71.4.3299-3306.1997 / J Virol / Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome by Balague (1997)
  125. 10.1165/ajrcmb.11.5.7946381 / Am J Respir Cell Mol Biol / Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration by Flotte (1994)
  126. 10.1002/j.1460-2075.1992.tb05614.x / EMBO J / Characterization of a preferred site on human chromosome 19q for integration of adenoassociated virus DNA by non-homologous recombination by Kotin (1992)
  127. 10.1073/pnas.93.21.11288 / Proc Natl Acad Sci USA / Site-specific integration by adeno-associated virus by Linden (1996)
  128. 10.1073/pnas.91.19.8915 / Proc Natl Acad Sci USA / Adeno-associated virus vectors preferentially transduce cells in S phase by Russell (1994)
  129. 10.1128/JVI.71.10.7951-7959.1997 / J Virol / Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome by Surosky (1997)
  130. {'key': '10.1038/sj.neo.7900056_bib130', 'series-title': 'Hum Gene Ther', 'article-title': 'Gene transfer to the nigrostriatal system by hybrid HSV/AAV amplicon vectors', 'author': 'Constantini', 'year': '1999'} / Hum Gene Ther / Gene transfer to the nigrostriatal system by hybrid HSV/AAV amplicon vectors by Constantini (1999)
  131. 10.1016/0092-8674(89)90433-9 / Cell / The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication by Gahn (1989)
  132. 10.1128/JVI.68.6.4067-4071.1994 / J Virol / Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1 by Middleton (1994)
  133. {'key': '10.1038/sj.neo.7900056_bib133', 'first-page': '1081', 'article-title': 'Engineering a miniherpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes', 'volume': '3', 'author': 'Sun', 'year': '1996', 'journal-title': 'Gene Ther'} / Gene Ther / Engineering a miniherpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes by Sun (1996)
  134. {'key': '10.1038/sj.neo.7900056_bib134', 'first-page': '503', 'article-title': 'Long-term gene expression from autonomously replicating vectors in mammalian cells', 'volume': '3', 'author': 'Wohlgemuth', 'year': '1996', 'journal-title': 'Gene Ther'} / Gene Ther / Long-term gene expression from autonomously replicating vectors in mammalian cells by Wohlgemuth (1996)
  135. 10.1073/pnas.81.12.3806 / Proc Natl Acad Sci USA / A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells by Yates (1984)
  136. 10.1128/JVI.70.12.8422-8430.1996 / J Virol / A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo by Wang (1996)
  137. 10.1038/sj.gt.3300523 / Gene Ther / A novel herpesvirus amplicon system for in vivo gene delivery by Wang (1997)
  138. 10.1128/JVI.73.12.10426-10439.1999 / J Virol / Single-step conversion of cells to retrovirus vector producers with HSV/EBV hybrid amplicons by Sena-Esteves (1999)
  139. 10.1523/JNEUROSCI.13-03-00941.1993 / J Neurosci / HSV-1 vectormediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding by Battleman (1993)
  140. 10.1007/BF02935542 / Mol Neurobio / Molecular analysis of the function of the neuronal growth-associated protein GAP-43 by genetic intervention by Neve (1991)
  141. 10.1073/pnas.90.13.6165 / Proc Natl Acad Sci USA / Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GIuR6 subunit of the kainate receptor by Bergold (1993)
  142. 10.1046/j.1471-4159.1995.65020842.x / J Neurochem / Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults by Ho (1995)
  143. 10.1089/hum.1996.7.2-173 / Hum Gene Ther / Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration by Geschwind (1996)
  144. 10.1046/j.1471-4159.1998.70062336.x / J Neurochem / Defining responsiveness of avian cochlear neurons to brain-derived neurotrophic factor and nerve growth factor by HSV-1-mediated gene transfer by Garrido (1998)
  145. 10.1073/pnas.92.16.7247 / Proc Natl Acad Sci USA / Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss by Lawrence (1995)
  146. 10.1097/00004647-199603000-00001 / J Cereb Blood Flow Metab / Over-expression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke by Lawrence (1996)
  147. 10.1097/00004647-199707000-00003 / J Cereb Blood Flow Metab / Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke by Lawrence (1997)
  148. 10.1161/01.STR.26.9.1670 / Stroke / Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia by Linnik (1995)
  149. 10.1126/science.266.5189.1399 / Science / Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase by During (1994)
  150. 10.1038/nbt0197-57 / Nat Biotechnol / Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase by Brooks (1997)
  151. 10.1016/0014-4886(92)90196-W / Exp Neurol / Introduction of a foreign gene (Escherichia coli IacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study by Huang (1992)
  152. 10.1006/exnr.1994.1192 / Exp Neurol / Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting by Wood (1994)
  153. 10.1016/0165-0270(94)00150-F / J Neurosci Methods / Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects by Ho (1995)
  154. 10.1089/hum.1994.5.8-987 / Hum Gene Ther / Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain by Pakzaban (1994)
  155. {'key': '10.1038/sj.neo.7900056_bib155', 'first-page': '283', 'article-title': 'Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors', 'volume': '1', 'author': 'Wood', 'year': '1994', 'journal-title': 'Gene Ther'} / Gene Ther / Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors by Wood (1994)
  156. {'issue': 'suppl 1', 'key': '10.1038/sj.neo.7900056_bib156', 'first-page': 'S82', 'article-title': 'Immunological consequences of HSV-1-mediated gene transfer into the CNS', 'volume': '1', 'author': 'Wood', 'year': '1994', 'journal-title': 'Gene Ther'} / Gene Ther / Immunological consequences of HSV-1-mediated gene transfer into the CNS by Wood (1994)
  157. {'key': '10.1038/sj.neo.7900056_bib157', 'first-page': '66', 'article-title': 'Gene delivery by helper virus-free defective herpes viral vectors', 'volume': '01', 'author': 'Jacobs', 'year': '1999', 'journal-title': 'J Gene Med.'} / J Gene Med. / Gene delivery by helper virus-free defective herpes viral vectors by Jacobs (1999)
  158. 10.1016/S0165-0270(97)00207-0 / J Neurosci Methods / Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector by Brooks (1998)
  159. {'key': '10.1038/sj.neo.7900056_bib159', 'article-title': 'Stereotactic intracerebral catheter implantation and continuous intratumoral infusion of the liposome associated HSV-tk gene inpatients with recurrent, unresectable glioblastoma multiforme-Clinical protocol for a phase I/II study', 'author': 'Voges', 'year': '1998', 'journal-title': 'Keystone'} / Keystone / Stereotactic intracerebral catheter implantation and continuous intratumoral infusion of the liposome associated HSV-tk gene inpatients with recurrent, unresectable glioblastoma multiforme-Clinical protocol for a phase I/II study by Voges (1998)
  160. {'key': '10.1038/sj.neo.7900056_bib160', 'first-page': '5731', 'article-title': 'Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpres sion of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase', 'volume': '58', 'author': 'Moriuchi', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpres sion of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase by Moriuchi (1998)
  161. {'key': '10.1038/sj.neo.7900056_bib161', 'first-page': '222', 'article-title': 'Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma', 'volume': '4', 'author': 'Miyatake', 'year': '1997', 'journal-title': 'Cancer Gene Ther'} / Cancer Gene Ther / Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma by Miyatake (1997)
  162. 10.4049/jimmunol.160.9.4457 / J Immunol / In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity by Toda (1998)
  163. 10.3109/13550289809114514 / J Neurovirol / Targeting gene therapy vectors to CNS malignancies by Spear (1998)
  164. 10.1128/JVI.72.12.9683-9697.1998 / J Virol / Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells by Laquerre (1998)
  165. {'key': '10.1038/sj.neo.7900056_bib165', 'article-title': 'HSV-1 gC modified with his-tag replacing heparan sulfate binding domain is expressed in an HSV-1 amplicon vector targeting system', 'author': 'Spear', 'year': '1999', 'journal-title': 'ASGT'} / ASGT / HSV-1 gC modified with his-tag replacing heparan sulfate binding domain is expressed in an HSV-1 amplicon vector targeting system by Spear (1999)
  166. 10.1007/978-1-4615-5357-1_57 / Adv Exp Med Biol / Targeted adenoviral vectors for cancer gene therapy by Bilbao (1998)
  167. 10.1128/JVI.72.12.9706-9713.1998 / J Virol / An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism by Dmitriev (1998)
  168. 10.1128/JVI.72.3.1844-1852.1998 / J Virol / Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob by Krasnykh (1998)
  169. {'key': '10.1038/sj.neo.7900056_bib169', 'first-page': '5738', 'article-title': 'Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer', 'volume': '58', 'author': 'Miller', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer by Miller (1998)
  170. 10.1038/nbt1196-1574 / Nat Biotechnol / Targeted gene delivery by tropism-modified adenoviral vectors by Douglas (1996)
  171. {'key': '10.1038/sj.neo.7900056_bib171', 'first-page': '1447', 'article-title': "Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor", 'volume': '57', 'author': 'Goldman', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor by Goldman (1997)
  172. 10.1126/science.274.5286.373 / Science / An adenovirus mutant that replicates selectively in p53-deficient human tumor cells by Bischoff (1996)
  173. 10.1128/JVI.72.12.9470-9478.1998 / J Virol / Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells by Rothmann (1998)
  174. 10.1111/j.1750-3639.1994.tb00840.x / Brain Pathol / Structure and transcriptional regulation of the GFAP gene by Brenner (1994)
  175. 10.1038/sj.gt.3300621 / Gene Ther / Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RLi null mutant vector-potential glioblastoma targeting by McKie (1998)
  176. 10.1128/JVI.73.9.7556-7564.1999 / J Virol / B-myc promoter retargeting of herpes simplex virus’ γ34.5-mediated virulence towards tumor and cycling cells by Chung (1999)
  177. 10.1006/scbi.1995.0013 / Semin Cancer Biol / Transcriptional control by E2F by Adams (1995)
  178. 10.1200/JCO.1997.15.11.3301 / J Clin Oncol / Role of the retinoblastoma protein in the pathogenesis of human cancer by Sellers (1997)
  179. 10.1038/nm1097-1145 / Nat Med / Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector by Parr (1997)
  180. 10.1038/nm0597-515 / Nat Med / Targeting gene expression to hypoxic tumor cells by Dachs (1997)
  181. 10.1038/nm0895-786 / Nat Med / Spatial and temporal control of gene therapy using ionizing radiation by Hallahan (1995)
  182. 10.1038/335563a0 / Nature / GAL4-VP16 is an unusually potent transcriptional activator by Sadowski (1988)
  183. 10.1101/gad.7.5.857 / Genes Dev / GAL4 disrupts a repressing nucleosome during activation of GAL1 transcription in vivo by Axelrod (1993)
  184. 10.1006/exnr.1996.6395 / Exp Neurol / Development of an HSV-based vector for the treatment of Parkinson's disease by Fink (1997)
  185. {'key': '10.1038/sj.neo.7900056_bib185', 'first-page': '892', 'article-title': 'In vivo transgene activation from an HSVbased gene therapy vector by GAL4:vpl6', 'volume': '3', 'author': 'Oligino', 'year': '1996', 'journal-title': 'Gene Ther'} / Gene Ther / In vivo transgene activation from an HSVbased gene therapy vector by GAL4:vpl6 by Oligino (1996)
  186. 10.1016/0092-8674(92)90234-4 / Cell / The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor by Vegeto (1992)
  187. 10.1073/pnas.91.17.8180 / Proc Natl Acad Sci USA / A regulatory system for use in gene transfer by Wang (1994)
  188. 10.1038/sj.gt.3300612 / Gene Ther / Drug inducible transgene expression in brain using a herpes simplex virus vector by Oligino (1998)
  189. 10.1093/nar/25.14.2723 / Nucleic Acids Res / Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential by Baron (1997)
  190. 10.1016/S0076-6879(97)83014-5 / Methods Enzymol / Use of tetracycline-controlled gene expression systems to study mammalian cell cycle by Freundlieb (1997)
  191. 10.1073/pnas.89.12.5547 / Proc Natl Acad Sci USA / Tight control of gene expression in mammalian cells by tetracycline-responsive promoters by Gossen (1992)
  192. 10.1126/science.7792603 / Science / Transcriptional activation by tetracyclines in mammalian cells by Gossen (1995)
  193. 10.1016/0169-328X(96)00097-6 / Brain Res Mol Brain Res / Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system by Ho (1996)
  194. 10.1038/sj.gt.3300487 / Gene Ther / Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer by Fotaki (1997)
  195. {'key': '10.1038/sj.neo.7900056_bib195', 'article-title': 'HSV-1 infected-cell proteins influence the expression of a tetracycline-regulated transgene', 'author': 'Herrlinger', 'year': '1999', 'journal-title': 'Hum Gene Ther'} / Hum Gene Ther / HSV-1 infected-cell proteins influence the expression of a tetracycline-regulated transgene by Herrlinger (1999)
  196. 10.1038/sj.cgt.7700003 / Cancer Gene Ther / Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7 by Barnett (1999)
  197. {'key': '10.1038/sj.neo.7900056_bib197', 'first-page': '1840', 'article-title': 'Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, iron oxide particles to normal rat brain', 'volume': '147', 'author': 'Muldoon', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, iron oxide particles to normal rat brain by Muldoon (1995)
  198. 10.1073/pnas.92.21.9829 / Proc Natl Acad Sci USA / Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption by Nilaver (1995)
  199. 10.1089/hum.1995.6.12-1543 / Hum Gene Ther / Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms by Rainov (1995)
  200. {'key': '10.1038/sj.neo.7900056_bib200', 'first-page': '158', 'article-title': 'Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector', 'volume': '5', 'author': 'Rainov', 'year': '1998', 'journal-title': 'Cancer Gene Ther'} / Cancer Gene Ther / Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector by Rainov (1998)
  201. {'key': '10.1038/sj.neo.7900056_bib201', 'article-title': 'Neural stem cells migrate throughout and express foreign genes within experimental gliomas—a potential gene therapy approach to brain tumors', 'author': 'Aboody', 'year': '1999', 'journal-title': 'Nat Med'} / Nat Med / Neural stem cells migrate throughout and express foreign genes within experimental gliomas—a potential gene therapy approach to brain tumors by Aboody (1999)
  202. {'key': '10.1038/sj.neo.7900056_bib202', 'article-title': 'C17-2 neural progenitor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas', 'author': 'Herrlinger', 'year': '1999', 'journal-title': 'Gene Ther'} / Gene Ther / C17-2 neural progenitor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas by Herrlinger (1999)
Dates
Type When
Created 22 years, 11 months ago (Sept. 4, 2002, 2:50 p.m.)
Deposited 2 years, 4 months ago (April 20, 2023, 11:18 p.m.)
Indexed 2 months ago (June 18, 2025, 2:25 a.m.)
Issued 25 years, 9 months ago (Nov. 1, 1999)
Published 25 years, 9 months ago (Nov. 1, 1999)
Published Print 25 years, 9 months ago (Nov. 1, 1999)
Funders 0

None

@article{Jacobs_1999, title={HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and Applications}, volume={1}, ISSN={1476-5586}, url={http://dx.doi.org/10.1038/sj.neo.7900056}, DOI={10.1038/sj.neo.7900056}, number={5}, journal={Neoplasia}, publisher={Elsevier BV}, author={Jacobs, Andreas and Breakefield, Xandra O. and Fraefel, Cornel}, year={1999}, month=nov, pages={402–416} }